Gene target prediction of differentially expressed microRNAs
| Gene annotation (symbol) . | microRNA ID . | TargetScan score . | miRanda energy score . |
|---|---|---|---|
| ADP ribosylation factor 5 (ARF5) | hsa-miR-3120-3p_1ss9GT | 87 | –13.5 |
| FKBP prolyl isomerase 4 (FKBP4) | PC-3p-208867_70 | 93 | –19.72 |
| FKBP prolyl isomerase 4 (FKBP4) | hsa-miR-1255a | 73 | –44.01 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-1255a | 50 | –18.09 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-1304-3p_1ss13CA | 82 | –20.50 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-20a-5p | 66 | –30.95 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-3120-3p_1ss9GT | 81 | –12.45 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-532-3p | 63 | –58.52 |
| NADH-ubiquinone oxidoreductase complex assembly factor 7 (NDUFAF7) | hsa-miR-941 | 99 | –20.54 |
| alpha-l-fucosidase 2 (FUCA2) | PC-3p-208867_70 | 72 | –12.18 |
| alpha-l-fucosidase 2 (FUCA2) | hsa-miR-1304-3p_1ss13CA | 81 | –18.62 |
| alpha-l-fucosidase 2 (FUCA2) | hsa-miR-139-5p_1ss9GT | 79 | –27.04 |
| alpha-l-fucosidase 2 (FUCA2) | hsa-miR-142-3p_R-1 | 98 | –19.16 |
| alpha-l-fucosidase 2 (FUCA2) | hsa-miR-20a-5p | 74 | –30.40 |
| heparan sulfate glucosamine 3-sulfotransferase 1 (HS3ST1) | PC-3p-208867_70 | 99 | –11.24 |
| heparan sulfate glucosamine3-sulfotransferase1 (HS3ST1) | hsa-miR-1304-3p_1ss13CA | 77 | –15.99 |
| heparan sulfate glucosamine3-sulfotransferase1 (HS3ST1) | hsa-miR-26a-1-3p | 89 | –25.90 |
| heparan sulfate glucosamine3-sulfotransferase1 (HS3ST1) | hsa-miR-3120-3p_1ss9GT | 72 | –16.25 |
| semaphorin 3F (SEMA3F) | hsa-miR-25-5p_R+2 | 94 | –18.49 |
| semaphorin 3F (SEMA3F) | hsa-miR-3158-3p_R-1 | 74 | –23.37 |
| CF transmembrane conductance regulator (CFTR) | PC-3p-48641_285 | 86 | –14.45 |
| cytochrome p450 family 51 subfamily A member 1 (CYP51A1) | hsa-miR-1304-3p_1ss13CA | 96 | –12.87 |
| ubiquitin specific peptidase 28 (USP28) | hsa-miR-1304-3p_1ss13CA | 93 | –15.17 |
| ubiquitin specific peptidase 28 (USP28) | hsa-miR-301a-3p | 95 | –15.63 |
| ubiquitin specific peptidase 28 (USP28) | hsa-miR-454-3p_R+2 | 93 | –13.24 |
| sperm tailPG-richrepeat containing 1 (STPG1) | PC-3p-208867_70 | 58 | –19.70 |
| sperm tailPG-richrepeat containing 1 (STPG1) | hsa-miR-532-3p | 94 | –21.41 |
| solute carrier family 7 member 2 (SLC7A2) | PC-3p-48641_285 | 61 | –16.32 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-1304-3p_1ss13CA | 94 | –56.97 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-146a-5p_1ss9GT | 61 | –12.98 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-20a-5p | 60 | –15.71 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-26a-1-3p | 69 | –24.58 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-3120-3p_1ss9GT | 57 | –114.84 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-486-5p | 87 | –17.37 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-532-3p | 90 | –40.46 |
| heat shock protein family B (small) member 6 (HSPB6) | hsa-miR-25-5p_R+2 | 89 | –38.41 |
| heat shock protein family B (small) member 6 (HSPB6) | hsa-miR-6735-5p_R-4 | 90 | –29.25 |
| pyruvate dehydrogenase kinase 4 (PDK4) | hsa-miR-532-3p | 83 | –18.45 |
| USH1 protein network component harmonin (USH1C) | hsa-miR-142-3p_R-1 | 78 | –19.36 |
| USH1 protein network component harmonin (USH1C) | hsa-miR-6735-5p_R-4 | 75 | –31.63 |
| RAS likeproto-oncogeneA (RALA) | hsa-miR-139-5p_1ss9GT | 60 | –11.26 |
| RAS likeproto-oncogeneA (RALA) | hsa-miR-301a-3p | 89 | –14.09 |
| RAS likeproto-oncogeneA (RALA) | hsa-miR-454-3p_R+2 | 89 | –17.18 |
| RAS likeproto-oncogeneA (RALA) | hsa-miR-532-3p | 77 | –28.50 |
| B cell receptor associated protein 29 (BCAP29) | hsa-miR-301a-3p | 59 | –26.11 |
| B cell receptor associated protein 29 (BCAP29) | hsa-miR-454-3p_R+2 | 63 | –26.93 |
| B cell receptor associated protein 29 (BCAP29) | hsa-miR-6735-5p_R-4 | 64 | –73.17 |
| BAR/IMD domain containing adaptor protein 2 like 1 (BAIAP2L1) | hsa-miR-6735-5p_R-4 | 57 | –65.25 |
| RNA polymerase II associated protein 3 (RPAP3) | PC-3p-48641_285 | 95 | –12.57 |
| RNA polymerase II associated protein 3 (RPAP3) | hsa-miR-1255a | 51 | –18.99 |
| RNA polymerase II associated protein 3 (RPAP3) | hsa-miR-139-5p_1ss9GT | 71 | –19.47 |
| uridine phosphorylase 2 (UPP2) | hsa-miR-1255a | 99 | –11.09 |
| uridine phosphorylase 2 (UPP2) | hsa-miR-146a-5p_1ss9GT | 99 | –12.59 |
| uridine phosphorylase 2 (UPP2) | hsa-miR-26a-1-3p | 50 | –20.71 |
| homeobox A11 (HOXA11) | hsa-miR-532-3p | 79 | –17.59 |
| C-X3-Cmotif chemokine ligand 1 (CX3CL1) | hsa-miR-20a-5p | 55 | –13.69 |
| C-X3-Cmotif chemokine ligand 1 (CX3CL1) | hsa-miR-6735-5p_R-4 | 71 | –150.88 |
| CEA cell adhesion molecule 7 (CEACAM7) | hsa-miR-3120-3p_1ss9GT | 55 | –19.40 |
| CEA cell adhesion molecule 7 (CEACAM7) | hsa-miR-6735-5p_R-4 | 94 | –17.76 |
| rhomboid domain containing 2 (RHBDD2) | hsa-miR-6735-5p_R-4 | 86 | –48.16 |
| oxysterol binding protein like 7 (OSBPL7) | hsa-miR-1304-3p_1ss13CA | 55 | –23.05 |
| oxysterol binding protein like 7 (OSBPL7) | hsa-miR-6735-5p_R-4 | 62 | –52.65 |
| NADH: ubiquinone oxidoreductase subunit AB1 (NDUFAB1) | hsa-miR-1304-3p_1ss13CA | 77 | –20.64 |
| integrin subunit alpha 3 (ITGA3) | hsa-miR-3120-3p_1ss9GT | 74 | –14.05 |
| cryptochrome circadian regulator 1 (CRY1) | hsa-miR-146a-5p_1ss9GT | 91 | –20.38 |
| cryptochrome circadian regulator 1 (CRY1) | hsa-miR-301a-3p | 86 | –14.94 |
| cryptochrome circadian regulator 1 (CRY1) | hsa-miR-454-3p_R+2 | 82 | –10.37 |
| STARD3 N-terminal like (STARD3NL) | PC-3p-48641_285 | 85 | –22.34 |
| STARD3 N-terminal like (STARD3NL) | hsa-miR-1304-3p_1ss13CA | 97 | –15.16 |
| CD74 molecule (CD74) | PC-3p-208867_70 | 60 | –19.51 |
| CD74 molecule (CD74) | hsa-miR-1255a | 85 | –43.07 |
| CD74 molecule (CD74) | hsa-miR-532-3p | 83 | –17.95 |
| synaptophysin like 1 (SYPL1) | hsa-miR-142-3p_R-1 | 83 | –14.84 |
| synaptophysin like 1 (SYPL1) | hsa-miR-3120-3p_1ss9GT | 62 | –10.73 |
| synaptophysin like 1 (SYPL1) | hsa-miR-486-5p | 87 | –12.65 |
| RAN binding protein 9 (RANBP9) | hsa-miR-532-3p | 71 | –23.39 |
| pleckstrin homology and RhoGEF domain containing G6 (PLEKHG6) | hsa-miR-532-3p | 58 | –24.82 |
| pleckstrin homology and RhoGEF domain containing G6 (PLEKHG6) | hsa-miR-6735-5p_R-4 | 76 | –44.22 |
| vacuolar protein sorting 13 homolog D (VPS13D) | PC-3p-48641_285 | 67 | –18.56 |
| vacuolar protein sorting 13 homolog D (VPS13D) | hsa-miR-301a-3p | 98 | –17.82 |
| vacuolar protein sorting 13 homolog D (VPS13D) | hsa-miR-454-3p_R+2 | 97 | –14.07 |
| tetraspanin 9 (TSPAN9) | hsa-miR-1304-3p_1ss13CA | 51 | –36.07 |
| tetraspanin 9 (TSPAN9) | hsa-miR-6735-5p_R-4 | 50 | –124.32 |
| glutaminyl-peptidecyclotransferase-like(QPCTL) | PC-3p-208867_70 | 72 | –13.72 |
| glutaminyl-peptidecyclotransferase-like(QPCTL) | hsa-miR-1304-3p_1ss13CA | 59 | –24.63 |
| glutaminyl-peptidecyclotransferase-like(QPCTL) | hsa-miR-25-5p_R+2 | 83 | –21.50 |
| HIVEP zinc finger 2 (HIVEP2) | hsa-miR-301a-3p | 94 | –11.43 |
| HIVEP zinc finger 2 (HIVEP2) | hsa-miR-454-3p_R+2 | 94 | –15.18 |
| HIVEP zinc finger 2 (HIVEP2) | hsa-miR-532-3p | 76 | –47.97 |
| ubiquitin protein ligase E3 component n-recognin 7 (UBR7) | hsa-miR-139-5p_1ss9GT | 57 | –11.59 |
| ubiquitin protein ligase E3 component n-recognin 7 (UBR7) | hsa-miR-301a-3p | 88 | –27.41 |
| ubiquitin protein ligase E3 component n-recognin 7 (UBR7) | hsa-miR-454-3p_R+2 | 89 | –27.50 |
| indolethylamine N-methyltransferase (INMT) | hsa-miR-486-5p | 55 | –15.57 |
| abhydrolase domain containing 5, lysophosphatidic acid acyltransferase (ABHD5) | hsa-miR-146a-5p_1ss9GT | 94 | –18.01 |
| Gprotein-coupledreceptor class C group 5 member A (GPRC5A) | hsa-miR-1255a | 94 | –51.69 |
| Gprotein-coupledreceptor class C group 5 member A (GPRC5A) | hsa-miR-142-3p_R-1 | 63 | –34.07 |
| Gprotein-coupledreceptor class C group 5 member A (GPRC5A) | hsa-miR-3120-3p_1ss9GT | 55 | –31.85 |
| Gprotein-coupledreceptor class C group 5 member A (GPRC5A) | hsa-miR-532-3p | 93 | –50.65 |
| cytochrome c oxidase assembly homolog COX15 (COX15) | PC-3p-208867_70 | 83 | –17.63 |
| Gene annotation (symbol) . | microRNA ID . | TargetScan score . | miRanda energy score . |
|---|---|---|---|
| ADP ribosylation factor 5 (ARF5) | hsa-miR-3120-3p_1ss9GT | 87 | –13.5 |
| FKBP prolyl isomerase 4 (FKBP4) | PC-3p-208867_70 | 93 | –19.72 |
| FKBP prolyl isomerase 4 (FKBP4) | hsa-miR-1255a | 73 | –44.01 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-1255a | 50 | –18.09 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-1304-3p_1ss13CA | 82 | –20.50 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-20a-5p | 66 | –30.95 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-3120-3p_1ss9GT | 81 | –12.45 |
| cytochrome p450 family 26 subfamily B member 1 (CYP26B1) | hsa-miR-532-3p | 63 | –58.52 |
| NADH-ubiquinone oxidoreductase complex assembly factor 7 (NDUFAF7) | hsa-miR-941 | 99 | –20.54 |
| alpha-l-fucosidase 2 (FUCA2) | PC-3p-208867_70 | 72 | –12.18 |
| alpha-l-fucosidase 2 (FUCA2) | hsa-miR-1304-3p_1ss13CA | 81 | –18.62 |
| alpha-l-fucosidase 2 (FUCA2) | hsa-miR-139-5p_1ss9GT | 79 | –27.04 |
| alpha-l-fucosidase 2 (FUCA2) | hsa-miR-142-3p_R-1 | 98 | –19.16 |
| alpha-l-fucosidase 2 (FUCA2) | hsa-miR-20a-5p | 74 | –30.40 |
| heparan sulfate glucosamine 3-sulfotransferase 1 (HS3ST1) | PC-3p-208867_70 | 99 | –11.24 |
| heparan sulfate glucosamine3-sulfotransferase1 (HS3ST1) | hsa-miR-1304-3p_1ss13CA | 77 | –15.99 |
| heparan sulfate glucosamine3-sulfotransferase1 (HS3ST1) | hsa-miR-26a-1-3p | 89 | –25.90 |
| heparan sulfate glucosamine3-sulfotransferase1 (HS3ST1) | hsa-miR-3120-3p_1ss9GT | 72 | –16.25 |
| semaphorin 3F (SEMA3F) | hsa-miR-25-5p_R+2 | 94 | –18.49 |
| semaphorin 3F (SEMA3F) | hsa-miR-3158-3p_R-1 | 74 | –23.37 |
| CF transmembrane conductance regulator (CFTR) | PC-3p-48641_285 | 86 | –14.45 |
| cytochrome p450 family 51 subfamily A member 1 (CYP51A1) | hsa-miR-1304-3p_1ss13CA | 96 | –12.87 |
| ubiquitin specific peptidase 28 (USP28) | hsa-miR-1304-3p_1ss13CA | 93 | –15.17 |
| ubiquitin specific peptidase 28 (USP28) | hsa-miR-301a-3p | 95 | –15.63 |
| ubiquitin specific peptidase 28 (USP28) | hsa-miR-454-3p_R+2 | 93 | –13.24 |
| sperm tailPG-richrepeat containing 1 (STPG1) | PC-3p-208867_70 | 58 | –19.70 |
| sperm tailPG-richrepeat containing 1 (STPG1) | hsa-miR-532-3p | 94 | –21.41 |
| solute carrier family 7 member 2 (SLC7A2) | PC-3p-48641_285 | 61 | –16.32 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-1304-3p_1ss13CA | 94 | –56.97 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-146a-5p_1ss9GT | 61 | –12.98 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-20a-5p | 60 | –15.71 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-26a-1-3p | 69 | –24.58 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-3120-3p_1ss9GT | 57 | –114.84 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-486-5p | 87 | –17.37 |
| solute carrier family 7 member 2 (SLC7A2) | hsa-miR-532-3p | 90 | –40.46 |
| heat shock protein family B (small) member 6 (HSPB6) | hsa-miR-25-5p_R+2 | 89 | –38.41 |
| heat shock protein family B (small) member 6 (HSPB6) | hsa-miR-6735-5p_R-4 | 90 | –29.25 |
| pyruvate dehydrogenase kinase 4 (PDK4) | hsa-miR-532-3p | 83 | –18.45 |
| USH1 protein network component harmonin (USH1C) | hsa-miR-142-3p_R-1 | 78 | –19.36 |
| USH1 protein network component harmonin (USH1C) | hsa-miR-6735-5p_R-4 | 75 | –31.63 |
| RAS likeproto-oncogeneA (RALA) | hsa-miR-139-5p_1ss9GT | 60 | –11.26 |
| RAS likeproto-oncogeneA (RALA) | hsa-miR-301a-3p | 89 | –14.09 |
| RAS likeproto-oncogeneA (RALA) | hsa-miR-454-3p_R+2 | 89 | –17.18 |
| RAS likeproto-oncogeneA (RALA) | hsa-miR-532-3p | 77 | –28.50 |
| B cell receptor associated protein 29 (BCAP29) | hsa-miR-301a-3p | 59 | –26.11 |
| B cell receptor associated protein 29 (BCAP29) | hsa-miR-454-3p_R+2 | 63 | –26.93 |
| B cell receptor associated protein 29 (BCAP29) | hsa-miR-6735-5p_R-4 | 64 | –73.17 |
| BAR/IMD domain containing adaptor protein 2 like 1 (BAIAP2L1) | hsa-miR-6735-5p_R-4 | 57 | –65.25 |
| RNA polymerase II associated protein 3 (RPAP3) | PC-3p-48641_285 | 95 | –12.57 |
| RNA polymerase II associated protein 3 (RPAP3) | hsa-miR-1255a | 51 | –18.99 |
| RNA polymerase II associated protein 3 (RPAP3) | hsa-miR-139-5p_1ss9GT | 71 | –19.47 |
| uridine phosphorylase 2 (UPP2) | hsa-miR-1255a | 99 | –11.09 |
| uridine phosphorylase 2 (UPP2) | hsa-miR-146a-5p_1ss9GT | 99 | –12.59 |
| uridine phosphorylase 2 (UPP2) | hsa-miR-26a-1-3p | 50 | –20.71 |
| homeobox A11 (HOXA11) | hsa-miR-532-3p | 79 | –17.59 |
| C-X3-Cmotif chemokine ligand 1 (CX3CL1) | hsa-miR-20a-5p | 55 | –13.69 |
| C-X3-Cmotif chemokine ligand 1 (CX3CL1) | hsa-miR-6735-5p_R-4 | 71 | –150.88 |
| CEA cell adhesion molecule 7 (CEACAM7) | hsa-miR-3120-3p_1ss9GT | 55 | –19.40 |
| CEA cell adhesion molecule 7 (CEACAM7) | hsa-miR-6735-5p_R-4 | 94 | –17.76 |
| rhomboid domain containing 2 (RHBDD2) | hsa-miR-6735-5p_R-4 | 86 | –48.16 |
| oxysterol binding protein like 7 (OSBPL7) | hsa-miR-1304-3p_1ss13CA | 55 | –23.05 |
| oxysterol binding protein like 7 (OSBPL7) | hsa-miR-6735-5p_R-4 | 62 | –52.65 |
| NADH: ubiquinone oxidoreductase subunit AB1 (NDUFAB1) | hsa-miR-1304-3p_1ss13CA | 77 | –20.64 |
| integrin subunit alpha 3 (ITGA3) | hsa-miR-3120-3p_1ss9GT | 74 | –14.05 |
| cryptochrome circadian regulator 1 (CRY1) | hsa-miR-146a-5p_1ss9GT | 91 | –20.38 |
| cryptochrome circadian regulator 1 (CRY1) | hsa-miR-301a-3p | 86 | –14.94 |
| cryptochrome circadian regulator 1 (CRY1) | hsa-miR-454-3p_R+2 | 82 | –10.37 |
| STARD3 N-terminal like (STARD3NL) | PC-3p-48641_285 | 85 | –22.34 |
| STARD3 N-terminal like (STARD3NL) | hsa-miR-1304-3p_1ss13CA | 97 | –15.16 |
| CD74 molecule (CD74) | PC-3p-208867_70 | 60 | –19.51 |
| CD74 molecule (CD74) | hsa-miR-1255a | 85 | –43.07 |
| CD74 molecule (CD74) | hsa-miR-532-3p | 83 | –17.95 |
| synaptophysin like 1 (SYPL1) | hsa-miR-142-3p_R-1 | 83 | –14.84 |
| synaptophysin like 1 (SYPL1) | hsa-miR-3120-3p_1ss9GT | 62 | –10.73 |
| synaptophysin like 1 (SYPL1) | hsa-miR-486-5p | 87 | –12.65 |
| RAN binding protein 9 (RANBP9) | hsa-miR-532-3p | 71 | –23.39 |
| pleckstrin homology and RhoGEF domain containing G6 (PLEKHG6) | hsa-miR-532-3p | 58 | –24.82 |
| pleckstrin homology and RhoGEF domain containing G6 (PLEKHG6) | hsa-miR-6735-5p_R-4 | 76 | –44.22 |
| vacuolar protein sorting 13 homolog D (VPS13D) | PC-3p-48641_285 | 67 | –18.56 |
| vacuolar protein sorting 13 homolog D (VPS13D) | hsa-miR-301a-3p | 98 | –17.82 |
| vacuolar protein sorting 13 homolog D (VPS13D) | hsa-miR-454-3p_R+2 | 97 | –14.07 |
| tetraspanin 9 (TSPAN9) | hsa-miR-1304-3p_1ss13CA | 51 | –36.07 |
| tetraspanin 9 (TSPAN9) | hsa-miR-6735-5p_R-4 | 50 | –124.32 |
| glutaminyl-peptidecyclotransferase-like(QPCTL) | PC-3p-208867_70 | 72 | –13.72 |
| glutaminyl-peptidecyclotransferase-like(QPCTL) | hsa-miR-1304-3p_1ss13CA | 59 | –24.63 |
| glutaminyl-peptidecyclotransferase-like(QPCTL) | hsa-miR-25-5p_R+2 | 83 | –21.50 |
| HIVEP zinc finger 2 (HIVEP2) | hsa-miR-301a-3p | 94 | –11.43 |
| HIVEP zinc finger 2 (HIVEP2) | hsa-miR-454-3p_R+2 | 94 | –15.18 |
| HIVEP zinc finger 2 (HIVEP2) | hsa-miR-532-3p | 76 | –47.97 |
| ubiquitin protein ligase E3 component n-recognin 7 (UBR7) | hsa-miR-139-5p_1ss9GT | 57 | –11.59 |
| ubiquitin protein ligase E3 component n-recognin 7 (UBR7) | hsa-miR-301a-3p | 88 | –27.41 |
| ubiquitin protein ligase E3 component n-recognin 7 (UBR7) | hsa-miR-454-3p_R+2 | 89 | –27.50 |
| indolethylamine N-methyltransferase (INMT) | hsa-miR-486-5p | 55 | –15.57 |
| abhydrolase domain containing 5, lysophosphatidic acid acyltransferase (ABHD5) | hsa-miR-146a-5p_1ss9GT | 94 | –18.01 |
| Gprotein-coupledreceptor class C group 5 member A (GPRC5A) | hsa-miR-1255a | 94 | –51.69 |
| Gprotein-coupledreceptor class C group 5 member A (GPRC5A) | hsa-miR-142-3p_R-1 | 63 | –34.07 |
| Gprotein-coupledreceptor class C group 5 member A (GPRC5A) | hsa-miR-3120-3p_1ss9GT | 55 | –31.85 |
| Gprotein-coupledreceptor class C group 5 member A (GPRC5A) | hsa-miR-532-3p | 93 | –50.65 |
| cytochrome c oxidase assembly homolog COX15 (COX15) | PC-3p-208867_70 | 83 | –17.63 |